Indian Army Department Of Military Affairs Pharmaceutical & Medical Consumables Tender 2025
Indian Army
Bid Publish Date
25-Apr-2025, 9:26 am
Bid End Date
16-May-2025, 10:00 am
Location
Progress
RAQuantity
47290
A tender has been published for Indian Navy Succinylchloline Chloride 50 mg per ml, 2 ml Inj, Cap Tacrolimus 0. 25 mg, Flavoxate 200mg Tab, Erythropoeitin Human Recombinant 4000 IU, Papaverine Hydrochloride 50 mg, 2 ml Inj, Sevelamer Carbonate Sachet 800mg, Human Insulin Analogue Glargine Inj, 100 IU per ml, Recombinant DNA origin, 300 IU disposable pen with 5 needles per pen, Gentamicin sulphate 0. 3 percent, gentamicin base with Hydrocortisone acetate IP 1 percent weight in volume eye and ear drops bott of 5 ml, Brimonidine Tartrate 0. 2 percent, Eye drops, Clobazam 5 mg Tab, Lorazepam 2 mg per ml, 2 ml Inj, Gabapentin 300 mg Cap or Tab, Sodium Valproate 100 mg per ml Inj, Lamotrigine 25 mg Tab, Sumatriptan 50 mg Tab, Topiramate 25 mg Tab, Nimodipine 30 mg Tab, Canagliflozin 100mg tab, Carbimazole 20 mg Tab, Tab Tenofovir 300mg, Tab Entacavir 0. 5mg, Omeprazole 20 mg Cap, Pantoprazole 40mg Inj, Ranitidine HCl 50 mg, 2 ml Inj, Metoclopramide syrup 5mg per 5ml bott of 30ml, Hydrocortisone Enema 10 percentage, Dicyclomine HCl 20 mg Inj, Tab or Cap Dicyclomine 10mg, Bisacodyl 5 mg Tab, Sodium phosphate solution 45 ml, each Pack of 2 bottle, Tab Dapagliflozin 10mg, Iron Syp Pediatric Each 5 ml Containing elemental iron of 50 mg as iron polymaltose complex in 200 m. . . , Baclofen XL 30 mg Tab, Clozapine 50 mg Tab, Ranolazine 500 mg Tab, Oral Contraceptive Pills-Mala D Ethinyl Estradiol 0. 03 mg, Norgestrel 0. 30 mg Tab in UTTARA KANNADA, KARNATAKA. Quantity: 47290 by. Submission Deadline: 16-05-2025 10: 00: 00. Check eligibility and apply.
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS
Indian Army
Indian Army
JALANDHAR, PUNJAB
Indian Army
Indian Army
PATIALA, PUNJAB
Indian Army
Tender Results
Loading results...
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | Succinylchloline Chloride 50 mg per ml, 2 ml Inj | Succinylchloline Chloride 50 mg per ml, 2 ml Inj | 100 | no | oicmsptj2 | 30 |
| 2 | Cap Tacrolimus 0.25 mg | Cap Tacrolimus 0.25 mg | 2,000 | no | oicmsptj2 | 30 |
| 3 | Flavoxate 200mg Tab | Flavoxate 200mg Tab | 900 | no | oicmsptj2 | 30 |
| 4 | Erythropoeitin Human Recombinant 4000 IU | Erythropoeitin Human Recombinant 4000 IU | 18 | no | oicmsptj2 | 30 |
| 5 | Papaverine Hydrochloride 50 mg, 2 ml Inj | Papaverine Hydrochloride 50 mg, 2 ml Inj | 100 | no | oicmsptj2 | 30 |
| 6 | Sevelamer Carbonate Sachet 800mg | Sevelamer Carbonate Sachet 800mg | 120 | no | oicmsptj2 | 30 |
| 7 | Human Insulin Analogue Glargine Inj, 100 IU per ml, Recombinant DNA origin, 300 IU disposable pen with 5 needles per pen | Human Insulin Analogue Glargine Inj, 100 IU per ml, Recombinant DNA origin, 300 IU disposable pen with 5 needles per pen | 240 | no | oicmsptj2 | 30 |
| 8 | Gentamicin sulphate 0.3 percent, gentamicin base with Hydrocortisone acetate IP 1 percent weight in volume eye and ear drops bott of 5 ml | Gentamicin sulphate 0.3 percent, gentamicin base with Hydrocortisone acetate IP 1 percent weight in volume eye and ear drops bott of 5 ml | 30 | no | oicmsptj2 | 30 |
| 9 | Brimonidine Tartrate 0.2 percent, Eye drops | Brimonidine Tartrate 0.2 percent, Eye drops | 50 | no | oicmsptj2 | 30 |
| 10 | Clobazam 5 mg Tab | Clobazam 5 mg Tab | 3,300 | no | oicmsptj2 | 30 |
| 11 | Lorazepam 2 mg per ml, 2 ml Inj | Lorazepam 2 mg per ml, 2 ml Inj | 480 | no | oicmsptj2 | 30 |
| 12 | Gabapentin 300 mg Cap or Tab | Gabapentin 300 mg Cap or Tab | 7,200 | no | oicmsptj2 | 30 |
| 13 | Sodium Valproate 100 mg per ml Inj | Sodium Valproate 100 mg per ml Inj | 300 | no | oicmsptj2 | 30 |
| 14 | Lamotrigine 25 mg Tab | Lamotrigine 25 mg Tab | 660 | no | oicmsptj2 | 30 |
| 15 | Sumatriptan 50 mg Tab | Sumatriptan 50 mg Tab | 3,000 | no | oicmsptj2 | 30 |
| 16 | Topiramate 25 mg Tab | Topiramate 25 mg Tab | 780 | no | oicmsptj2 | 30 |
| 17 | Nimodipine 30 mg Tab | Nimodipine 30 mg Tab | 360 | no | oicmsptj2 | 30 |
| 18 | Canagliflozin 100mg tab | Canagliflozin 100mg tab | 3,600 | no | oicmsptj2 | 30 |
| 19 | Carbimazole 20 mg Tab | Carbimazole 20 mg Tab | 180 | no | oicmsptj2 | 30 |
| 20 | Tab Tenofovir 300mg | Tab Tenofovir 300mg | 180 | no | oicmsptj2 | 30 |
| 21 | Tab Entacavir 0.5mg | Tab Entacavir 0.5mg | 180 | no | oicmsptj2 | 30 |
| 22 | Omeprazole 20 mg Cap | Omeprazole 20 mg Cap | 11,000 | no | oicmsptj2 | 30 |
| 23 | Pantoprazole 40mg Inj | Pantoprazole 40mg Inj | 1,950 | no | oicmsptj2 | 30 |
| 24 | Ranitidine HCl 50 mg, 2 ml Inj | Ranitidine HCl 50 mg, 2 ml Inj | 1,900 | no | oicmsptj2 | 30 |
| 25 | Metoclopramide syrup 5mg per 5ml bott of 30ml | Metoclopramide syrup 5mg per 5ml bott of 30ml | 72 | no | oicmsptj2 | 30 |
| 26 | Hydrocortisone Enema 10 percentage | Hydrocortisone Enema 10 percentage | 30 | no | oicmsptj2 | 30 |
| 27 | Dicyclomine HCl 20 mg Inj | Dicyclomine HCl 20 mg Inj | 540 | no | oicmsptj2 | 30 |
| 28 | Tab or Cap Dicyclomine 10mg | Tab or Cap Dicyclomine 10mg | 1,300 | no | oicmsptj2 | 30 |
| 29 | Bisacodyl 5 mg Tab | Bisacodyl 5 mg Tab | 1,000 | no | oicmsptj2 | 30 |
| 30 | Sodium phosphate solution 45 ml, each Pack of 2 bottle | Sodium phosphate solution 45 ml, each Pack of 2 bottle | 180 | no | oicmsptj2 | 30 |
| 31 | Tab Dapagliflozin 10mg | Tab Dapagliflozin 10mg | 1,800 | no | oicmsptj2 | 30 |
| 32 | Iron Syp Pediatric Each 5 ml Containing elemental iron of 50 mg as iron polymaltose complex in 200 m... | Iron Syp Pediatric Each 5 ml Containing elemental iron of 50 mg as iron polymaltose complex in 200 m... | 2,000 | no | oicmsptj2 | 30 |
| 33 | Baclofen XL 30 mg Tab | Baclofen XL 30 mg Tab | 1,080 | no | oicmsptj2 | 30 |
| 34 | Clozapine 50 mg Tab | Clozapine 50 mg Tab | 180 | no | oicmsptj2 | 30 |
| 35 | Ranolazine 500 mg Tab | Ranolazine 500 mg Tab | 300 | no | oicmsptj2 | 30 |
| 36 | Oral Contraceptive Pills-Mala D Ethinyl Estradiol 0.03 mg, Norgestrel 0.30 mg Tab | Oral Contraceptive Pills-Mala D Ethinyl Estradiol 0.03 mg, Norgestrel 0.30 mg Tab | 180 | no | oicmsptj2 | 30 |
Discover companies most likely to bid on this tender
Start
25-May-2025, 2:00 pm
End
02-Jun-2025, 12:00 pm
Duration: 190 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
Key insights about KARNATAKA tender market
The eligibility requirements include being a registered entity with relevant experience in pharmaceutical supply, possessing the necessary accreditations and licenses mandated by Indian health authorities, and demonstrating a proven track record of timely delivery and compliance with quality standards in similar contracts. Potential bidders should ensure their qualifications align with the objectives outlined in the tender documentation.
Bidders must submit several required certificates, including compliance with Good Manufacturing Practices (GMP), valid licenses for the production and supply of pharmaceuticals, and certificates of analysis for each batch of products. All submitted documents must verify adherence to quality standards delineated by the Central Drugs Standard Control Organization (CDSCO).
The registration process requires bidders to create an account on the designated government e-marketplace platform. After successful registration, vendors must verify their credentials and ensure compliance with the eligibility criteria specified in the tender documentation before proceeding to submit their offers.
Among the accepted document formats, bidders should use common file types such as PDF, DOCX, and XLSX. It is essential to refer to the submission guidelines provided with the tender for any specific formatting requirements that may pertain to the documents submitted.
The tender includes special provisions for MSEs that encourage participation by providing benefits such as relaxed qualification criteria, financial advantages, and additional support to help smaller firms compete with larger suppliers. This initiative aims to enhance the participation of MSEs in government contracts and promote local production capabilities.
Sign up now to access all documents
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS